<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CBBDE17F-AE17-4C90-9CA6-DAF6835B3E48"><gtr:id>CBBDE17F-AE17-4C90-9CA6-DAF6835B3E48</gtr:id><gtr:name>Procter &amp; Gamble</gtr:name><gtr:address><gtr:line1>1 Procter and Gamble Plaza</gtr:line1><gtr:line4>Cincinnati</gtr:line4><gtr:line5>OH 45202</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9D53091E-603E-4B64-B5EC-6430D28827FD"><gtr:id>9D53091E-603E-4B64-B5EC-6430D28827FD</gtr:id><gtr:name>Syngenta</gtr:name><gtr:address><gtr:line1>WRO-1004.1.51</gtr:line1><gtr:line2>Schwarzwaldallee 215</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Chemistry</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CBBDE17F-AE17-4C90-9CA6-DAF6835B3E48"><gtr:id>CBBDE17F-AE17-4C90-9CA6-DAF6835B3E48</gtr:id><gtr:name>Procter &amp; Gamble</gtr:name><gtr:address><gtr:line1>1 Procter and Gamble Plaza</gtr:line1><gtr:line4>Cincinnati</gtr:line4><gtr:line5>OH 45202</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9D53091E-603E-4B64-B5EC-6430D28827FD"><gtr:id>9D53091E-603E-4B64-B5EC-6430D28827FD</gtr:id><gtr:name>Syngenta</gtr:name><gtr:address><gtr:line1>WRO-1004.1.51</gtr:line1><gtr:line2>Schwarzwaldallee 215</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/29278D49-D1DF-4EF7-806B-7E5DB06874F1"><gtr:id>29278D49-D1DF-4EF7-806B-7E5DB06874F1</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Law</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B6BBA762-EF49-47C2-B10F-1F96AF42DAFF"><gtr:id>B6BBA762-EF49-47C2-B10F-1F96AF42DAFF</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Seddon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9FA7C5E6-E30B-4DFF-95F9-DA0926CD4D13"><gtr:id>9FA7C5E6-E30B-4DFF-95F9-DA0926CD4D13</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Templer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F1BF75F0-C952-4A52-A437-5A52F79EF29C"><gtr:id>F1BF75F0-C952-4A52-A437-5A52F79EF29C</gtr:id><gtr:firstName>Oscar</gtr:firstName><gtr:surname>Ces</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B410E3D4-91C5-45FA-83E4-36A35EEF9262"><gtr:id>B410E3D4-91C5-45FA-83E4-36A35EEF9262</gtr:id><gtr:firstName>Laura</gtr:firstName><gtr:otherNames>Mary</gtr:otherNames><gtr:surname>Barter</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FH024425%2F1"><gtr:id>477F766A-919E-4394-A5F1-773C2BC0F44B</gtr:id><gtr:title>Elements of a Vesicle Machine</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/H024425/1</gtr:grantReference><gtr:abstractText>Despite cells being thought of as the smallest unit of life, they are actually made up smaller components that give them the ability to perform functions such as self-repair, and produce and harness energy. These components consists of large collections of proteins and lipids, the building blocks of cells, that actually work together to create higher level functions. A useful analogy is that of a city and a cell. A city often requires a wall (an outer lipid membrane), power plants (mitochondria from animal cells, and chloroplasts from plant cells) and factories and engineering firms to repair the city infrastructure (lipid homeostatic machinery). Each of these units is run by workers and machinery (lipids and proteins).In this project, we aim to take apart cells, but not at the level of the workers , instead at the level of the city infrastructure and bring them back together in a different combination with a view to constructing a new city (novel self-assembling micron scale machinery). These components, that we will be 'hi-jacking' from cells will be housed within artificial lipid vesicles that will provide a housing which mimics the ability of cells to ring-fence and protect their infrastructure. It is not yet known which components can be coupled in this manner and this is something that we aim to explore.</gtr:abstractText><gtr:potentialImpactText>Our goal is to explore the feasibility of generating hybrid, self-sustaining microscale machinery (HSSMMs) using an approach which is distinct from any other grouping. We will combine and manipulate gross elements of cellular machinery including mitochondrial organelles, lipid biosynthetic machinery and ion channel couples into lipid vesicles. We aim to demonstrate that these elements are isolatable and can constitute systems in their own right that can be coupled to create systems that are paradoxically more than the sum of the whole. Whilst replication is fundamental to the property of any living cell, here we choose to disregard this aspect and concentrate solely upon the ability of the HSSMMs to act as power sources that can be coupled to external systems and adapt to changes in their external environment. We believe that our high risk strategy of commandeering isolated components of the cell machinery and quantifying the interdependence of these modules will have wide ranging implications in the academic community and beyond. It would represent a novel approach, distinct to that of Synthetic Biology. In the short-term (12-18 months), the cross-disciplinary approach that is vital to tackling this strategy will bring together researchers within and thereby strengthen the cross-disciplinary networks at Imperial College, in particular the Chemical Biology Centre (CBC) and the Membrane Biophysics Platform (MBP). These feasibilities studies and their continued long term exploitation (24 months-10 years) will stimulate involvement in disciplines of chemistry, engineering, physics, mathematics, biophysics and biology. In addition to the standard methods of dissemination, meeting conferences and peer reviewed publications, we will make extensive of the MBP online Sharepoint facility and continue to organise 'Ideas Workshops'. The latter two have proven to be excellent methods of dissemination and already link over 60 research groups. In the longer term (10-15 years), HSSMMs capable of using light or mitochondrial organelles to generate ATP, which can be used as an energy currency, have the potential to revolutionise power sources for Micro-Electrical-Mechanical Systems (MEMs). By demonstrating the feasibility of first generation HSSMMs we will unlock the potential for more complex systems that can underpin novel in-vivo delivery and biosensor applications in the healthcare sector. Whilst these applications are somewhat in the future, it is vital that we capture the new IP and identify killer applications by engaging early on with the industrial sector, both during and after the feasibility studies. Our patent strategy through IC Innovations, will allow us to protect this new IP before engaging the community via established routes such the Technology Strategy Board Knowledge Transfer Networks and the CBC Technology Showcase events. The project and its deliverables sit within three of the priority research themes of the EPSRC (Nanoscience Through Engineering to Application; Energy; Towards Next Generation Healthcare). The two early careers researchers, the key resource for these studies will acquire extensive experience of systems integration and technology transfer, transferable skills that are vital to the continued future success of the academic, biotechnology and nanotechnology sectors. This exciting project is likely to stimulate increase public awareness of nanoscience. We will capitalise upon this by commissioning audio-visual content associated with our feasibility studies (e.g. recording of conference lectures or school lectures); these will then be uploaded onto facilities such as iTunesU and YouTube so that the general public can freely download this material.</gtr:potentialImpactText><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2010-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>201409</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Procter &amp; Gamble</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration with Proctor and Gamble</gtr:description><gtr:id>3BA5607B-F06D-4195-9AD3-2B9F500295BD</gtr:id><gtr:outcomeId>b963ed04b963ed18-1</gtr:outcomeId><gtr:piContribution>Collaboration with Proctor and Gamble (supported by CASE studentship)
EPSRC CASE Studentship starting in October 2012.
We are also in discussions with P and G with a view to funding an associated PDRA as well.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Syngenta</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Syngenta Ltd (Bracknell)</gtr:department><gtr:description>Collaboration with Syngenta</gtr:description><gtr:id>A9B524BF-2D04-4519-9B5F-2CA84FC6FA9D</gtr:id><gtr:impact>Collaboration just started, exploring potential of the technology: multi-disciplinary activity.</gtr:impact><gtr:outcomeId>546272a7ec8401.02006781-1</gtr:outcomeId><gtr:partnerContribution>Exploitation of DIB platform for studying membrane translocation in plant systems.</gtr:partnerContribution><gtr:piContribution>Development of DIB platform</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>International Microfluidics Congress</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CDA9F34C-47A2-40FE-8AC2-A0F0992A48DE</gtr:id><gtr:impact>International conference: disseminate findings of research and look for new end users of the technology</gtr:impact><gtr:outcomeId>56deea30b09c37.93751149</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Technology showcase presentation to industry (AstraZeneca)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>946808A8-1FB4-48B3-AC9A-1607B536635B</gtr:id><gtr:impact>Workshop and associated talk aimed at translating EPSRC breakthrough to industry.</gtr:impact><gtr:outcomeId>56deeb6478c151.21134742</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to the general public (Friends of Imperial College)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DE87C66A-CDBD-4226-8D06-F332A8D71198</gtr:id><gtr:impact>Presentation aimed at addressing public concerning associated with manufacturing artificial cells and manipulating biological systems.</gtr:impact><gtr:outcomeId>56deec997bba19.05302116</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>71400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC CDT PhD Studentship: Drug-membrane interaction screens</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>BE7BA63E-7BE5-49DC-AF8F-9C61AE32F88D</gtr:id><gtr:outcomeId>5eddd6f25eddd706</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3260000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie Initial Training Network: NextGenAgriChem</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>58CCFA2A-9DF8-454D-B5AD-B74141314BAC</gtr:id><gtr:outcomeId>54623988d5b455.72577752</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5160000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Frontier Manufacturing: Scaling Up Synthetic Biology (EP/K038648/1)</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/K038648/1</gtr:fundingRef><gtr:id>7A3E045C-14AC-4921-B475-958AD02799E6</gtr:id><gtr:outcomeId>546238ee7a3e62.53352087</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>95000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC CDT PhD Studentship (Engineering communication in artificial cells)</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>109FD6B8-CCE3-4382-B275-1E788CA324E3</gtr:id><gtr:outcomeId>5eddd4ea5eddd4fe</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>67000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Industrial CASE Studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>F2148CCE-E5F4-446D-AFF8-A45B1CFC8BCD</gtr:id><gtr:outcomeId>5edded725edded86</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Joint collaboration: Protocell technologies for Healthcare</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>9EDD1544-A2A6-42E2-BFAB-6290B7540D29</gtr:id><gtr:outcomeId>56dee792428980.96870064</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4772920</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Programme Grant (Sculpting Dynamic Amphiphilic Surfaces), EP/J017566/1</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/J017566/1</gtr:fundingRef><gtr:id>ADA587B2-3A59-421F-B36B-D9310ACB407A</gtr:id><gtr:outcomeId>5edb54905edb54a4</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC DTG Studentship (awarded through the Department of Chemistry): Optical Traps+DIBs</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>57195659-5EDF-4058-B51A-0FC1D085E96D</gtr:id><gtr:outcomeId>5eddf6465eddf65a</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>74400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Pathways to Impact Funding</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>7C6426D0-4AFF-4D5D-9E63-EA65BCE51667</gtr:id><gtr:outcomeId>5edd63665edd637a</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The aim of our feasibility account was to investigate how self-assembling amphiphilic structures and various sub-cellular components can be coupled together to make hybrid, self-sustaining microscale machinery (HSSMMs). Our proof-of concept studies on the hybrid, self-sustaining microscale machinery (HSSMM) project proved extremely successful enabling us to demonstrate that it is possible to produce HSSMMs that can move, produce and or release a cargo in response to external stimuli. Since their development they have been exploited in applications ranging from smart delivery systems, bottom-up artificial cell construction, in-situ drug synthesis and biological microreactors for industrial synthetic biology.</gtr:description><gtr:id>41A16F0D-2480-40B5-A6BF-F46D4D991C45</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>m-3407874995.291116de257f1c</gtr:outcomeId><gtr:sector>Chemicals,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Our feasibility studies on the hybrid, self-sustaining microscale machinery (HSSMM) project have allowed us to demonstrate that it is possible to produce HSSMMs that can move, produce and or release a cargo in response to external stimuli. This has been achieved by hijacking and manipulating component parts of a living cell's machinery and making them function in simplified contexts within HSSMMs. This set of experiments have established an exciting portfolio of potential technological applications for these micromachines including chemical synthesis, chemical sensing and molecular delivery. 

These pilot studies will make a significant contribution to innovation in the UK industry, with a 10-15 year timeframe for commercial realisation and have strengthened cross-disciplinary networks across the UK bringing together 7 research groups at the Institute of Chemical Biology at Imperial College and the University of Bristol. Our results have underpinned: (i) a successful bid for an EPSRC Programme grant and Frontier Engineering grant (ii) numerous publications (iii) a Royal Society International Meeting where we presented our feasibility roadmap (v) &amp;gt;10 seminars including numerous presentations to industry and (vi) a CDT studentship with Kings College. The PDRAs on the project have benefitted from multi-disciplinary research training and we expect them to be future research leaders as exemplified by 4 follow-on fellowship applications submitted to build upon their contribution to this project.
Research highlights include constructing HSSMMs with the ability to:
1. drive a rotary engine embedded within the containment capsule of a HSSMM. This motor has the potential to drive a micro-propeller that we have produced and that is capable of generating thrust. This engine is driven by ATP (Adenosine-5'- triphosphate). We also demonstrated that in the future it should be possible to regenerate this ATP fuel source using chloroplasts and mitochondria as bio-inspired batteries transplanted from living cells. In the coming months we aim to couple these &amp;quot;batteries&amp;quot; with the molecular rotary engine.
2. release a pre-packaged cargo in response to a specific external stimulus. This microdelivery device couples a membrane based containment capsule with two molecular machines (A and B). The first (A) modifies the mechanical properties of the containment capsule by altering its chemical composition without compromising structural integrity. The second module (B), embedded within the membrane consists of a channel which can open or close depending on the mechanical properties of the membrane which it can sense. Following the action of module A, module B opens thereby releasing an onboard cargo. During these experiments we have been able to show for the first time that by harnessing nanoscale energetics within membranes, we can drive information flow between molecular machines without the requirement of direct contact. This system is now being translated to a microfluidic device with a view to manufacturing an insulin delivery system.
3. manufacture an onboard cargo in response to sensing the presence of an external small molecule. This HSSMM contains a linear DNA genome with the genetic information required to produce a coloured gene product after detecting the presence of a specific small molecule, in this case a sugar. This HSSMM mimics the ability of living cells to adapt their response to the environment by altering gene expression. We have also started the development of HSSMMs that couple cargo production with light and evolve over generations.

In addition, we have developed high-throughput platforms for generating 2-D and 3-D microfluidic droplet interface bilayer (DIBs) networks. These can be used to build up complex HSSMM systems and are now being exploited in two follow-on projects with commercial collaborators. These technologies breakthrough downstream enabled us to develop microfluidic strategies for manufacturing compartmentalised vesicles following the project which thereby tackled a long standing bottleneck in the biotech industry.</gtr:description><gtr:exploitationPathways>This programme will make a significant contribution to innovation in UK industry, with a 5-15 year timeframe for commercial realisation. Our early stage proof of concept studies on HSSMM technologies have demonstrated that they have the potential to drive new strategies and approaches to drug molecule-membrane screening (1-5 years), drug delivery (5 years), drug release (5 years), in-situ bio-diagnostics and sensors (5-10 years), small molecule detection/tracking (5-10 years) and the biological microreactors. The latter application is in advanced PoC stages of testing.</gtr:exploitationPathways><gtr:id>16FA5D16-3C38-45D6-B423-4E3021DCBA83</gtr:id><gtr:outcomeId>r-4495492777.317289774f9eb4</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>We have demonstrated for the first time that it is possible to engineer protein-protein communication between proteins, without the need for direct contact by using biological membranes as the information highway. This technology is now being further developed to manufacture artificial cells/organelles and will help to unlock our understanding of protein-protein communication networks in cells.</gtr:description><gtr:id>7D870F82-042C-4061-BE0C-F6359AD59728</gtr:id><gtr:impact>Has underpinned the development of a new generation of bottom-up artificial cells capable of sensing their environment. It has in effect introduced a new engineering component into the design of protocells</gtr:impact><gtr:outcomeId>r-7315864281.0917136fd469b4</gtr:outcomeId><gtr:title>Membrane based protein-protein communication</gtr:title><gtr:type>New/Improved Technique/Technology</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>Using microfludic platforms we can now manufacture droplet interface bilayer networks using the contours of microfluidic chips to control the shape of the networks whilst also using the delivery flow rate and droplet size to influence droplet packing geometries with the host chambers. These new approaches allow individual droplet position and composition to be controlled, paving the way for complex on-chip funtional network synthesis and bespoke scaffolds for artificial cells, organelles and hybrid self-sustaining micromachinery. Industrial applications are currently being pursued.</gtr:description><gtr:id>07EF64D1-D826-47B0-8093-D388EBA5C6C8</gtr:id><gtr:outcomeId>r-7301615129.5058576fd46c3e</gtr:outcomeId><gtr:title>Microfluidic generation of 2-D and 3-D droplet interface bilayer networks</gtr:title><gtr:type>New/Improved Technique/Technology</gtr:type></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>809CFF80-DD45-486C-81AD-9A4020829E18</gtr:id><gtr:title>Novel technologies for the formation of 2-D and 3-D droplet interface bilayer networks.</gtr:title><gtr:parentPublicationTitle>Lab on a chip</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd736bcc2e432de71bf435bf4b94d711"><gtr:id>fd736bcc2e432de71bf435bf4b94d711</gtr:id><gtr:otherNames>Elani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1473-0189</gtr:issn><gtr:outcomeId>5462248992a8c7.24485371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8274AAB9-7ECE-4366-A644-5844E44BA40E</gtr:id><gtr:title>Vesicle-based artificial cells: recent developments and prospects for drug delivery.</gtr:title><gtr:parentPublicationTitle>Therapeutic delivery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd736bcc2e432de71bf435bf4b94d711"><gtr:id>fd736bcc2e432de71bf435bf4b94d711</gtr:id><gtr:otherNames>Elani Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-5990</gtr:issn><gtr:outcomeId>585d642eb5daa1.48044307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6038B69-C2B6-4A8B-B8DF-DB8137CD224A</gtr:id><gtr:title>The effect of hydrostatic pressure on model membrane domain composition and lateral compressibility.</gtr:title><gtr:parentPublicationTitle>Physical chemistry chemical physics : PCCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a268d81e38e3426fe080dfc79193dc8a"><gtr:id>a268d81e38e3426fe080dfc79193dc8a</gtr:id><gtr:otherNames>Barriga HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1463-9076</gtr:issn><gtr:outcomeId>585d5c47990260.27470449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E4BEDAA-C6D7-4AC9-994D-F75C91FFB734</gtr:id><gtr:title>Light-activated control of protein channel assembly mediated by membrane mechanics.</gtr:title><gtr:parentPublicationTitle>Nanotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba128d2a1d4957ccef811a41ce522626"><gtr:id>ba128d2a1d4957ccef811a41ce522626</gtr:id><gtr:otherNames>Miller DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0957-4484</gtr:issn><gtr:outcomeId>5a578ab1aeb683.42358834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43D75BD3-20CF-4550-9F56-B0F205C8E59B</gtr:id><gtr:title>Engineering de novo membrane-mediated protein-protein communication networks.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fb7bf7527a2eff6611d55f8352539a3"><gtr:id>3fb7bf7527a2eff6611d55f8352539a3</gtr:id><gtr:otherNames>Charalambous K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>doi_53d0170179f335a5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>245F6B4A-ED12-4290-A73B-DA661923CC5D</gtr:id><gtr:title>Protocell design through modular compartmentalization.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03de1f255575aa0fed6c0378444c73af"><gtr:id>03de1f255575aa0fed6c0378444c73af</gtr:id><gtr:otherNames>Miller D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>5462252e9ae841.19782377</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/H024425/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>53F27348-198B-4AEF-A34B-8307067F507C</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Systems engineering</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>21CE2EA6-E7A2-4406-A045-0DA7CA19B695</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Control Engineering</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>DF4CD176-73D5-4039-BBC7-28D33DC364DD</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Synthetic biology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>